144 related articles for article (PubMed ID: 36218378)
21. Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
Tuckwell K; Collinson N; Dimonaco S; Klearman M; Blockmans D; Brouwer E; Cid MC; Dasgupta B; Rech J; Salvarani C; Unizony SH; Stone JH;
Semin Arthritis Rheum; 2017 Apr; 46(5):657-664. PubMed ID: 27998620
[TBL] [Abstract][Full Text] [Related]
22. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
Becker M
Praxis (Bern 1994); 2020; 109(5):347-354. PubMed ID: 32233763
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Pipitone N; Versari A; Hunder GG
Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
[TBL] [Abstract][Full Text] [Related]
24. Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
de Boysson H; Liozon E; Lambert M; Dumont A; Boutemy J; Maigné G; Martin Silva N; Ly KH; Manrique A; Bienvenu B; Aouba A
Am J Med; 2017 Aug; 130(8):992-995. PubMed ID: 28460851
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
[TBL] [Abstract][Full Text] [Related]
26. Role of
Slart RHJA; Nienhuis PH; Glaudemans AWJM; Brouwer E; Gheysens O; van der Geest KSM
J Nucl Med; 2023 Apr; 64(4):515-521. PubMed ID: 37011940
[TBL] [Abstract][Full Text] [Related]
27. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.
Hemmig AK; Gozzoli D; Werlen L; Ewald H; Aschwanden M; Blockmans D; Brouwer E; Buchanan RRC; Camellino D; Campochiaro C; Cimmino MA; Corominas H; Gloy V; Henckaerts L; Kyburz D; Moya-Alvarado P; Owen CE; Stegert M; Tomelleri A; van Sleen Y; Yamashita H; Imfeld S; Berger CT; Hemkens LG; Daikeler T
Semin Arthritis Rheum; 2022 Aug; 55():152017. PubMed ID: 35537222
[TBL] [Abstract][Full Text] [Related]
28. Cranial and large vessel activity on positron emission tomography scan at diagnosis and 6 months in giant cell arteritis.
Sammel AM; Hsiao E; Schembri G; Bailey E; Nguyen K; Brewer J; Schrieber L; Janssen B; Youssef P; Fraser CL; Laurent R
Int J Rheum Dis; 2020 Apr; 23(4):582-588. PubMed ID: 32100451
[TBL] [Abstract][Full Text] [Related]
29. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
30. Extracranial giant cell arteritis: A narrative review.
Lensen KD; Voskuyl AE; Comans EF; van der Laken CJ; Smulders YM
Neth J Med; 2016 Jun; 74(5):182-92. PubMed ID: 27323671
[TBL] [Abstract][Full Text] [Related]
31. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG
J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549
[TBL] [Abstract][Full Text] [Related]
32. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.
Yoshida M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Sugimura K; Fujii H; Shimokawa H; Harigae H
Int J Rheum Dis; 2016 Jan; 19(1):87-94. PubMed ID: 26443306
[TBL] [Abstract][Full Text] [Related]
34. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis of giant cell arteritis].
Greigert H; Bonnotte B; Samson M
Rev Prat; 2023 Apr; 73(4):387-394. PubMed ID: 37289151
[TBL] [Abstract][Full Text] [Related]
36. Large-Vessel Dilatation in Giant Cell Arteritis: A Different Subset of Disease?
Muratore F; Kermani TA; Crowson CS; Koster MJ; Matteson EL; Salvarani C; Warrington KJ
Arthritis Care Res (Hoboken); 2018 Sep; 70(9):1406-1411. PubMed ID: 29266882
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
Unizony S; McCulley TJ; Spiera R; Pei J; Sidiropoulos PN; Best JH; Birchwood C; Pavlov A; Stone JH
Arthritis Res Ther; 2021 Jan; 23(1):8. PubMed ID: 33407817
[TBL] [Abstract][Full Text] [Related]
38. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
[TBL] [Abstract][Full Text] [Related]
39. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
40. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
